Artax Biopharma to present Phase 2a data on Nck modulator AX-158, establishing novel mechanism of action in autoimmune disease at the 2025 SID Annual Meeting
Late breaker abstract presentation to showcase clinical validation of first-in-class oral small molecule AX-158 in cohort of patients with psoriasis
Full dataset to expand on previously announced topline results, reinforcing the potential of Nck modulation as a differentiated and transformative approach in autoimmune diseases
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announced that an abstract on the safety, efficacy and biomarker results of its Phase 2a study evaluating Nck modulator AX-158 in patients with psoriasis was accepted as a late breaking oral presentation at the Society for Investigative Dermatology (SID) Annual Meeting taking place May 7 – 10, 2025, in San Diego, California.
Dr. Chris VanDeusen, Chief Scientific Officer, will present 'AX-158 Proof-of-Mechanism Safety Study: Evaluating a Novel T cell Receptor (TCR) Signal Modulator in Patients with Mild-to-Moderate Plaque Psoriasis (NCT05725057),' final abstract ID number LB1150, on May 9, 2025, in the Concurrent Mini-symposium 11: Late-Breaking Abstracts session taking place from 8:30 to 11:15 am PT in the Aqua D/E/F room of the Hilton San Diego Bayfront Hotel.
Members of the Artax Biopharma management team will be present at the meeting. Please reach out via contact@artaxbiopharma to set up a meeting or request a copy of the presentation.
About Artax Biopharma
Artax Biopharma is a clinical-stage biotechnology company transforming the treatment of T Cell-driven autoimmune diseases. Artax's first-in-class oral small molecules aim to deliver immune system modulation without immunosuppression, potentially unlocking new treatment options as both monotherapy and in combination with other treatments. Artax Biopharma is based in the Boston area and raised funding from investors including Advent Life Sciences, Sound Bioventures, The Termeer Family Office, the Fuhrer Family Office and Columbus Venture Partners. For more info, see www.artaxbiopharma.com or follow us on LinkedIn.
About Nck modulation
We believe there is significant potential for Nck modulation to revolutionize treatment of T Cell-driven diseases. Immunomodulation maintains healthy control of the immune system, while addressing the underlying source of T Cell-driven diseases. Central to a well-functioning immune system is the T Cell Receptor (TCR). When TCR signaling becomes dysregulated, it causes T Cell-driven conditions, including autoimmune diseases. We believe the immunomodulation mechanism offered by our investigational agents holds broad potential to revolutionize how these T Cell-driven autoimmune diseases are addressed, while not impairing the ability of a patient's immune system to function properly.
AX-158, our lead Nck modulator, has shown strong, broad cytokine modulation as well as modulation of mixed lymphocyte reactions. Good data on therapeutic efficacy with AX-158 were observed in murine models of self-antigen activation (EAE), with a prolonged pharmacodynamic effect in EAE, suggesting durable immune modulation. AX-158 showed no immunosuppression in models of strong antigen stimulation. Studies with AX-158 showed substantial preclinical evidence of activity in the Th2, Th17, Th1/Th0 pathways, suggesting that applications could be quite broad across the autoimmune space.
For future clinical study inquiries: contact@artaxbiopharma.com
Contacts: Maria Nichol, DPhil, EPA, CPA Chief Business Officer mnichol@artaxbiopharma.com
Media: Madelin HawtinLifeSci Communicationsmhawtin@lifescicomms.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
What a Doctor wants you to know about Measles
SIOUX FALLS, S.D. (KELO) — The South Dakota Department of Health has reported the state's first case of measles in 2025. A man in Meade County developed the infection after traveling internationally. The most common symptoms of measles start off much like a cold, a cough, a runny nose, and red watery eyes, called conjunctivitis. 'That is accompanied by a fever, which is often very high, up to 104 105 degrees. Several days after those symptoms start, 4 or 5 days, is when the characteristic measles rash usually pops up. It's bright red, it starts at the hairline and works its way down the body,' said Doctor Ashley Sands, an infectious disease expert. Remembering The Children Memorial sculpture honors those who lost their lives What makes measles so dangerous is that it can cause pneumonia and encephalitis, which can be fatal. Measles is one of the most contagious infectious diseases known to man. To give you an idea of how contagious measles is, if someone in this room had coughed an hour ago. And if I walk through that airspace, I could become infected if I'm not vaccinated. Dr. Sands says the measles vaccine is very safe and very effective, and has been around since the 1960s. 'We know that with the first dose of measles given around one year of age, that confers around 93 percent immunity, meaning that of 100 people who receive the measles vaccine, 93 will be fully protected for the rest of their lives,' said Dr. Sands. Most people are vaccinated at 12 months old and receive a second dose at age second dose raises a person's protection from 93 percent to 97 in the rare case of a vaccinated person becoming infected, she says the infection is much less severe and contagious. If you are unsure if you were vaccinated as a child, doctors suggest talking with your can also check with your doctor or request your immunization records from the South Dakota Department of Health. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
30 minutes ago
- Yahoo
Eastern NC preparing a hurricane season officially underway
CARTERET COUNTY, N.C. (WNCT) — Hurricane season has begun and meteorologists with the National Weather Service are anticipating an active year. Warning Coordination Meteorologist for the National Weather Service Erik Heden stressed how long the season is and how important it is to be prepared early. Heden said the category of a hurricane should also not determine how well you prepare or how seriously you take a storm since it only relates to wind. He said 85 percent of hurricane-related deaths are due to water. 'During Florence, we also learned that we had a whole lot more flooding in areas that we've never had flooding before,' Carteret County Emergency Services Director Stephen Rea said. 'It's the whole county that's vulnerable.' Rea said it's important to have a weeks' worth of supplies in a hurricane preparedness kit including food, water, batteries and a weather radio. It's also important to have a strong evacuation plan. 'A shelter is a safe place, but it should be your last resort. It's not a hotel. It's not going to be a comfortable location,' Heden said. 'Try to go to a hotel either out of state or out of the area or all the people that come and visit you at the beach? Go visit them.' The National Weather Service is hosting a hurricane community forum at the Pine Knoll Shores Town Hall June 17th at 10 a.m. You can register here. Learn more about Carteret County's emergency preparedness here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
30 minutes ago
- Yahoo
Sioux Falls ramps up mosquito control
SIOUX FALLS, S.D. (KELO) — You may have noticed as the weather warms up, more mosquitoes are starting to show up, especially with all the rain we've been getting lately. That's why the city of Sioux Falls will soon ramp up its efforts to get the pesky insects under control. Todd Dickens likes to ride the city's bike trails, but what he doesn't like are mosquitoes. Thankfully, he says he hasn't had to worry about them yet. 1 dead in Monday I-90 crash 'Haven't had any problems with them, so I haven't really noticed them too much,' Dickens said. But the city is anticipating that'll change. 'We only need a couple of really warm days with the spring water we've been getting we could see that real big increase in the mosquito population,' Public Health Program Manager Jaimiee Roggenbauer said. Jaimiee Roggenbauer is the Public Health Program Manager. She says the city starts addressing the mosquito problem before it even happens. 'We go into the stagnant water around the city and we do what's called 'dipping' we look for larva before they are an adult mosquito and if we see it or suspect there's going to be larva in there we treat it on the spot and that prevents our adult mosquitoes from ever bothering anybody,' Roggenbauer said. They've also set up several mosquito traps around the city to test for West Nile. 'Those are going to start happening in late June or early July and we'll see them more at dawn and dusk and those are the ones that can give you West Nile if they bite you,' Roggenbauer said. They'll start spraying neighborhoods within the next couple of weeks, because it's only a matter of time. 'Well, with the recent rain, I could see that and as the temperatures get warmer, it's going to cause them to come out more, yeah, I could see that happening,' Dickens said. Roggenbauer says Sioux Falls has one of the highest numbers of West Nile cases per capita in the country. To learn more about the city's efforts for spraying or to get updates on your phone on which zones they'll be spraying in and when, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
